BFDV Vaccination Trial

an update

Nicolai Bonne, Patrick Shearer, Margaret Sharp, Phillip Clark, Shane Raidal

Research output: Book chapter/Published conference paperConference paper

1 Downloads (Pure)

Abstract

Psittacine beak and feather disease is a significant disease of both captive and wild psittacine birds worldwide (ref). Vaccination has proven an effective means of controlling the causative agent; beak and feather disease virus (BFDV)(Raidal et al., 1993). There have been attempts at culturing BFDV in numerous cell culture systems, however there have been no reports of successful virus amplification using cell cultures (Pass and Perry, 1985) and past vaccination trials have utilized virus eluted from feathers of infected birds (Raidal et al., 1993). Therefore, full length recombinant BFDV capsid protein was expressed using a baculovirus expression system. This recombinant protein has previously been proven to react with anti-BFDV sera from naturally immune psittacines and from chickens experimentally inoculated with native BFDV in both western immuno-blots and haemagglutination inhibition (HI) assay (Stewart et al., 2007). However, the use of baculovirus expressed recombinant protein for vaccination against BFDV has not been documented. Thus, we tested the protective properties of this recombinant protein using a flock of BFDV-free long-billed corellas (Cacatua tenurostris) (n=18).
Original languageEnglish
Title of host publicationAdvancing and Promoting Avian Medicine and Stewardship
EditorsGarry Cross
Place of PublicationMelbourne, Australia
PublisherAAVAC
Pages223-228
Number of pages6
Publication statusPublished - 2007
EventAssociation of Avian Veterinarians Australasian Committee (AAVAC) Annual Conference - Melbourne, Vic. Australia, Australia
Duration: 03 Oct 200706 Oct 2007

Conference

ConferenceAssociation of Avian Veterinarians Australasian Committee (AAVAC) Annual Conference
CountryAustralia
Period03/10/0706/10/07

Fingerprint

Beak and feather disease virus
vaccination
recombinant proteins
Baculoviridae
feathers
cell culture
viruses
hemagglutination inhibition test
birds
beak
coat proteins
flocks
chickens

Cite this

Bonne, N., Shearer, P., Sharp, M., Clark, P., & Raidal, S. (2007). BFDV Vaccination Trial: an update. In G. Cross (Ed.), Advancing and Promoting Avian Medicine and Stewardship (pp. 223-228). Melbourne, Australia: AAVAC.
Bonne, Nicolai ; Shearer, Patrick ; Sharp, Margaret ; Clark, Phillip ; Raidal, Shane. / BFDV Vaccination Trial : an update. Advancing and Promoting Avian Medicine and Stewardship. editor / Garry Cross. Melbourne, Australia : AAVAC, 2007. pp. 223-228
@inproceedings{b31f64ad42364989aed3f845e6a9790e,
title = "BFDV Vaccination Trial: an update",
abstract = "Psittacine beak and feather disease is a significant disease of both captive and wild psittacine birds worldwide (ref). Vaccination has proven an effective means of controlling the causative agent; beak and feather disease virus (BFDV)(Raidal et al., 1993). There have been attempts at culturing BFDV in numerous cell culture systems, however there have been no reports of successful virus amplification using cell cultures (Pass and Perry, 1985) and past vaccination trials have utilized virus eluted from feathers of infected birds (Raidal et al., 1993). Therefore, full length recombinant BFDV capsid protein was expressed using a baculovirus expression system. This recombinant protein has previously been proven to react with anti-BFDV sera from naturally immune psittacines and from chickens experimentally inoculated with native BFDV in both western immuno-blots and haemagglutination inhibition (HI) assay (Stewart et al., 2007). However, the use of baculovirus expressed recombinant protein for vaccination against BFDV has not been documented. Thus, we tested the protective properties of this recombinant protein using a flock of BFDV-free long-billed corellas (Cacatua tenurostris) (n=18).",
keywords = "Open access version available, BFDV, Baculovirus, Vaccination",
author = "Nicolai Bonne and Patrick Shearer and Margaret Sharp and Phillip Clark and Shane Raidal",
note = "Imported on 03 May 2017 - DigiTool details were: publisher = Melbourne, Australia: AAVAC, 2007. editor/s (773b) = Cross, Garry; Event dates (773o) = 3-6 October, 2007; Parent title (773t) = Association of Avian Veterinarians Australasian Committee (AAVAC) Annual Conference.",
year = "2007",
language = "English",
pages = "223--228",
editor = "Garry Cross",
booktitle = "Advancing and Promoting Avian Medicine and Stewardship",
publisher = "AAVAC",

}

Bonne, N, Shearer, P, Sharp, M, Clark, P & Raidal, S 2007, BFDV Vaccination Trial: an update. in G Cross (ed.), Advancing and Promoting Avian Medicine and Stewardship. AAVAC, Melbourne, Australia, pp. 223-228, Association of Avian Veterinarians Australasian Committee (AAVAC) Annual Conference, Australia, 03/10/07.

BFDV Vaccination Trial : an update. / Bonne, Nicolai; Shearer, Patrick; Sharp, Margaret; Clark, Phillip; Raidal, Shane.

Advancing and Promoting Avian Medicine and Stewardship. ed. / Garry Cross. Melbourne, Australia : AAVAC, 2007. p. 223-228.

Research output: Book chapter/Published conference paperConference paper

TY - GEN

T1 - BFDV Vaccination Trial

T2 - an update

AU - Bonne, Nicolai

AU - Shearer, Patrick

AU - Sharp, Margaret

AU - Clark, Phillip

AU - Raidal, Shane

N1 - Imported on 03 May 2017 - DigiTool details were: publisher = Melbourne, Australia: AAVAC, 2007. editor/s (773b) = Cross, Garry; Event dates (773o) = 3-6 October, 2007; Parent title (773t) = Association of Avian Veterinarians Australasian Committee (AAVAC) Annual Conference.

PY - 2007

Y1 - 2007

N2 - Psittacine beak and feather disease is a significant disease of both captive and wild psittacine birds worldwide (ref). Vaccination has proven an effective means of controlling the causative agent; beak and feather disease virus (BFDV)(Raidal et al., 1993). There have been attempts at culturing BFDV in numerous cell culture systems, however there have been no reports of successful virus amplification using cell cultures (Pass and Perry, 1985) and past vaccination trials have utilized virus eluted from feathers of infected birds (Raidal et al., 1993). Therefore, full length recombinant BFDV capsid protein was expressed using a baculovirus expression system. This recombinant protein has previously been proven to react with anti-BFDV sera from naturally immune psittacines and from chickens experimentally inoculated with native BFDV in both western immuno-blots and haemagglutination inhibition (HI) assay (Stewart et al., 2007). However, the use of baculovirus expressed recombinant protein for vaccination against BFDV has not been documented. Thus, we tested the protective properties of this recombinant protein using a flock of BFDV-free long-billed corellas (Cacatua tenurostris) (n=18).

AB - Psittacine beak and feather disease is a significant disease of both captive and wild psittacine birds worldwide (ref). Vaccination has proven an effective means of controlling the causative agent; beak and feather disease virus (BFDV)(Raidal et al., 1993). There have been attempts at culturing BFDV in numerous cell culture systems, however there have been no reports of successful virus amplification using cell cultures (Pass and Perry, 1985) and past vaccination trials have utilized virus eluted from feathers of infected birds (Raidal et al., 1993). Therefore, full length recombinant BFDV capsid protein was expressed using a baculovirus expression system. This recombinant protein has previously been proven to react with anti-BFDV sera from naturally immune psittacines and from chickens experimentally inoculated with native BFDV in both western immuno-blots and haemagglutination inhibition (HI) assay (Stewart et al., 2007). However, the use of baculovirus expressed recombinant protein for vaccination against BFDV has not been documented. Thus, we tested the protective properties of this recombinant protein using a flock of BFDV-free long-billed corellas (Cacatua tenurostris) (n=18).

KW - Open access version available

KW - BFDV

KW - Baculovirus

KW - Vaccination

M3 - Conference paper

SP - 223

EP - 228

BT - Advancing and Promoting Avian Medicine and Stewardship

A2 - Cross, Garry

PB - AAVAC

CY - Melbourne, Australia

ER -

Bonne N, Shearer P, Sharp M, Clark P, Raidal S. BFDV Vaccination Trial: an update. In Cross G, editor, Advancing and Promoting Avian Medicine and Stewardship. Melbourne, Australia: AAVAC. 2007. p. 223-228